Clinical trials
Phase 3 Anemia, Refractory, with Excess of Blasts trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2015 | 1 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Leukemia Research Fund | 1 |
| Medical Research Council | 1 |
| Riverside Haematology Group | 1 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 1 |
| Traws Pharma, Inc. | 1 |
| University of Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 8 |
| Myelodysplastic Syndromes | 7 |
| Leukemia | 5 |
| Leukemia, Myeloid, Acute | 3 |
| Congenital Abnormalities | 2 |
| Leukemia, Erythroblastic, Acute | 2 |
| Leukemia, Megakaryoblastic, Acute | 2 |
| Leukemia, Monocytic, Acute | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
| Leukemia, Myelomonocytic, Acute | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.